Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Financial Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 234,527 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Sale · Disposed 2,000 · Balance 234,527 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 207,814 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · derivative · entry 11 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 620,033 Underlying: Class A Common Stock · 207,814 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F9 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,700 | $0.00 Strike: $11.53 | $0.00 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · derivative · entry 10 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,832 Underlying: Class A Common Stock · 11,700 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F8 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 16,400 | $21.07 | $345,546.36 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 9 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,763 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.00 - $21.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 183,600 | $20.37 | $3,739,050.72 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 8 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,163 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.045 - $20.99. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 11,700 | $20.04 | $234,415.35 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 7 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 345,763 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.02 - $20.045. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 40,132 | $19.98 | $801,849.40 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 357,463 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95 - $20.02. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,326 | $19.95 | $126,203.70 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 397,595 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,193 | $19.95 | $183,394.83 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,921 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.82 - $20.015 The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 2,388 | $20.00 | $47,768.36 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 413,114 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 207,814 | $5.01 | $1,041,148.14 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 415,502 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:49 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,700 | $11.53 | $134,901.00 |
DisclosureSEC source: 0001773751-24-000321 · wk-form4_1729115389.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| October 07, 2024 Filed Oct 8, 2024 20:21 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,868 | $19.96 | $196,991.92 |
DisclosureSEC source: 0001773751-24-000315 · wk-form4_1728418867.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 195,988 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.95 - $19.985. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,437 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 827,847 Underlying: Class A Common Stock · 6,437 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F5 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 997 | $19.08 | $19,024.26 |
DisclosureSEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 205,856 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.02 - $19.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,391 | $19.04 | $26,482.55 |
DisclosureSEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 206,853 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.93 - $19.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,193 | $18.88 | $173,577.63 |
DisclosureSEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 208,244 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $18.77 - $19.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 20:09 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,437 | $5.01 | $32,249.37 |
DisclosureSEC source: 0001773751-24-000310 · wk-form4_1727986170.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 217,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| September 20, 2024 Filed Sep 23, 2024 20:35 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 12,651 | $16.79 | $212,355.89 |
DisclosureSEC source: 0001773751-24-000306 · wk-form4_1727123745.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 211,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.72 - $16.84. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:06 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 22,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 321,833 Underlying: Class A Common Stock · 22,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:06 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,344 Underlying: Class A Common Stock · 18,335 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:06 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 52,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,372 Underlying: Class A Common Stock · 52,395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:06 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 51,536 | $16.57 | $853,951.52 |
DisclosureSEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,651 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 23:06 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 93,718 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000295 · wk-form4_1726614402.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 9,199 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · derivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 834,284 Underlying: Class A Common Stock · 9,199 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F4 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,399 | $14.58 | $20,403.02 |
DisclosureSEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 181,469 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.55 - $14.64. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 1,008 | $14.59 | $14,703.29 |
DisclosureSEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,868 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.55 - $14.64. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3 | $14.60 | $43.80 |
DisclosureSEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,876 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,199 | $14.60 | $134,328.40 |
DisclosureSEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,879 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.55 - $14.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 9,199 | $5.01 | $46,086.99 |
DisclosureSEC source: 0001773751-24-000286 · wk-form4_1725575845.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 31, 2024 by the Reporting Person. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 6,430 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000272 · wk-form4_1723666546.xml · derivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843,483 Underlying: Class A Common Stock · 6,430 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 20:15 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 6,430 | $5.01 | $32,214.30 |
DisclosureSEC source: 0001773751-24-000272 · wk-form4_1723666546.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 25, 2024 Filed Jun 26, 2024 01:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 11,546 | $22.21 | $256,489.77 |
DisclosureSEC source: 0001773751-24-000213 · wk-form4_1719364942.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,449 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $22.16 - $22.285. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 22,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,821 Underlying: Class A Common Stock · 22,988 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,679 Underlying: Class A Common Stock · 18,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2023. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 52,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · derivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366,767 Underlying: Class A Common Stock · 52,395 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting 25% on March 15, 2023, and the remaining 75% vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"). Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 51,561 | $23.75 | $1,224,573.75 |
DisclosureSEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,995 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 21:26 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 93,717 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000198 · wk-form4_1718746009.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:36 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 7,396 | $0.00 Strike: $11.53 | $0.00 |
DisclosureSEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · derivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,532 Underlying: Class A Common Stock · 7,396 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F4 · derivative.exercise_date: The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:36 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 86,398 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · derivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 849,913 Underlying: Class A Common Stock · 86,398 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F3 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:36 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 98,635 | $21.42 | $2,113,225.28 |
DisclosureSEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,839 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · balance_after: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $21.14 - $21.725. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:36 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 7,396 | $11.53 | $85,275.88 |
DisclosureSEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 245,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:36 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 86,398 | $5.01 | $432,853.98 |
DisclosureSEC source: 0001773751-24-000176 · wk-form4_1718051810.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 28,084 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · derivative · entry 6 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 936,311 Underlying: Class A Common Stock · 28,084 shares Expires 2032-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F7 · derivative.exercise_date: 25% of the options will vest on the twelve (12) month anniversary of the Vesting Commencement Date of January 24, 2022. The balance of the shares shall vest in a series of thirty-six (36) successive equal monthly installments measured from the twelve (12) month anniversary of the Vesting Commencement Date, subject to optionholder's continuous Service (as defined in the Plan) as of each such vesting date. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,349 | $17.95 | $60,120.24 |
DisclosureSEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 5 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,680 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.86 - $18.07. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,349 | $17.97 | $60,190.91 |
DisclosureSEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 4 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 155,029 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.88 - $18.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 31,433 | $17.86 | $561,377.66 |
DisclosureSEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 158,378 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.63 - $18.15. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 21, 2024 Filed May 22, 2024 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 28,084 | $5.01 | $140,700.84 |
DisclosureSEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 189,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: The stock option exercises reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:16 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,900 | $20.01 | $138,043.47 |
DisclosureSEC source: 0001773751-24-000152 · wk-form4_1716408990.xml · nonDerivative · entry 1 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 161,727 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.00 - $20.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,304 | $15.83 | $52,294.06 |
DisclosureSEC source: 0001773751-24-000088 · wk-form4_1711062467.xml · nonDerivative · entry 3 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,627 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.76 - $15.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 20, 2024 Filed Mar 21, 2024 23:07 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,304 | $15.82 | $52,261.68 |
DisclosureSEC source: 0001773751-24-000088 · wk-form4_1711062467.xml · nonDerivative · entry 2 Okupe Oluyemi · CIK 0001907056 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,931 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 10, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.76 - $15.88. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.